Bliss GVS Pharma Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bliss GVS Pharma Limited with three other
companies in this sector in India:
Astrazeneca Pharma India Ltd
sales of 5.64 billion Indian Rupees [US$84.56 million]
of which 98%
Neuland Laboratories Limited
(5.10 billion Indian Rupees [US$76.50 million]
of which 100%
was Bulk Drugs), and
Suven Life Sciences Limited
(5.00 billion Indian Rupees [US$74.93 million]
of which 94%
was Intermediaries under Contract Research/M).
During the year ended March of 2016, sales at
Bliss GVS Pharma Limited were 5.47 billion Indian Rupees (US$82.03 million).
increase of 34.3%
versus 2015, when the company's sales were 4.07 billion Indian Rupees.